The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Robert L. Frye, Malcolm R. Bell, Hartzell V. Schaff, Richard Holubkov, Katherine M. Detre

Research output: Contribution to journalReview article

1 Scopus citations


The role of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) in patients with diabetes mellitus (DM) is evolving. Data from clinical trials and observational studies are reviewed as well as current clinical practice guidelines. The importance of aggressive medical therapy to achieve recommended glycemic control targets, and management of usual risk factors in patients with coronary artery disease (CAD) cannot be overemphasized regardless of the revascularization therapy selected. Patients with type 2 diabetes are at increased risk for CAD, which is the cause of death in the majority of patients. Outcomes following PCI and CABG are worse in patients with DM compared to those without DM. This calls for randomized trials and other studies focused on patients with DM.

Original languageEnglish (US)
Pages (from-to)16-20
Number of pages5
JournalCurrent diabetes reports
Issue number1
StatePublished - Feb 2002


ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this